The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Hepatocellular carcinoma and hepatitis C in the United States
Open accessAbstract
Chronic infection with hepatitis C virus (HCV) is a major risk factor for development of hepatocellular carcinoma (HCC). In general, HCC develops only after 2 or more decades of HCV infection and the increased risk is restricted largely to patients with cirrhosis or advanced fibrosis. Factors that predispose to HCC among HCV-infected persons include male sex, older age, hepatitis B virus (HBV) coinfection, heavy alcohol intake, and possibly diabetes and a transfusion-related source of HCV infection. Viral factors play a minor role. The likelihood of development of HCC among HCV-infected persons is difficult to determine because of the paucity of adequate long-term cohort studies; the best estimate is 1% to 3% after 30 years. Once cirrhosis is established, however, HCC develops at an annual rate of 1% to 4%. Successful antiviral therapy of patients with HCV-related cirrhosis may reduce the future risk for HCC. The incidence of and mortality caused by all HCC has doubled in the United States over the past 25 years, an increase that has affected all ethnic groups, both sexes, and younger age groups. Given the current prevalence of HCV infection among persons 30 to 50 years of age, the incidence and mortality rates of HCC are likely to double in the United States over the next 10 to 20 years. Future research should focus on improving understanding of the incidence and risk factors for HCC, causes of HCV-related carcinogenesis, means of early detection, and better treatment for HCC. (Hepatology 2002;36:S74-S83).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rising Incidence of Hepatocellular Carcinoma in the United States
El-Serag, H. B., & Mason, A. C. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903113401001 · Cited by 2,853
Self-citationClinical Outcomes after Transfusion-Associated Hepatitis C
Tong, M. J., El-Farra, N. S., Reikes, A. R., & Co, R. L. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506013322202 · Cited by 1,198
Cryptogenic Cirrhosis: Clinical Characterization and Risk Factors for Underlying Disease
Caldwell, S. H., Oelsner, D. H., Iezzoni, J. C., Hespenheide, E. E., Battle, E. H., & Driscoll, C. J. (1999) · Hepatology · doi:10.1002/hep.510290347 · Cited by 1,143
Yoshida, H., Shiratori, Y., Moriyama, M., Arakawa, Y., Ide, T., Sata, M., Inoue, O., Yano, M., Tanaka, M., Fujiyama, S., et al. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-3-199908030-00003 · Cited by 1,096
Alter, M. J. (1997) · Hepatology · doi:10.1002/hep.510260711 · Cited by 1,075
Adinolfi, L. E., Gambardella, M., Andreana, A., Tripodi, M.-F., Utili, R., & Ruggiero, G. (2001) · Hepatology · doi:10.1053/jhep.2001.24432 · Cited by 1,059
Graham, C. S., Baden, L. R., Yu, E., Mrus, J. M., Carnie, J., Heeren, T., & Koziel, M. J. (2001) · Clinical Infectious Diseases · doi:10.1086/321909 · Cited by 974
Nishiguchi, S., Kuroki, T., Nakatani, S., Morimoto, H., Takeda, T., Nakajima, S., Shiomi, S., Seki, S., Kobayashi, K., & Otani, S. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91739-x · Cited by 857
Bruix, J., Calvet, X., Costa, J., Ventura, M., Bruguera, M., Castillo, R., María Barrera, J., Ercilla, G., María Sanchez-Tapias, J., Vall, M., et al. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91015-5 · Cited by 734
Donato, F. (2002) · American Journal of Epidemiology · doi:10.1093/aje/155.4.323 · Cited by 677
PREVALENCE OF ANTIBODIES TO HEPATITIS C VIRUS IN ITALIAN PATIENTS WITH HEPATOCELLULAR CARCINOMA
Colombo, M., Choo, Q. L., Del Ninno, E., Dioguardi, N., Kuo, G., Donato, M. F., Tommasini, M. A., & Houghton, M. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91016-7 · Cited by 666
Prognosis of Chronic Hepatitis C: Results of A Large, Prospective Cohort Study
Niederau, C., Lange, S., Heintges, T., Erhardt, A., Buschkamp, M., Hürter, D., Nawrocki, M., Kruska, L., Hensel, F., Petry, W., et al. (1998) · Hepatology · doi:10.1002/hep.510280632 · Cited by 636
Estimating progression to cirrhosis in chronic hepatitis C virus infection
Freeman, A. J., Dore, G. J., Law, M. G., Thorpe, M., Von Overbeck, J., Lloyd, A. R., Marinos, G., & Kaldor, J. M. (2001) · Hepatology · doi:10.1053/jhep.2001.27831 · Cited by 620
Estimating future hepatitis C morbidity, mortality, and costs in the United States
(2000) · American Journal of Public Health · doi:10.2105/ajph.90.10.1562 · Cited by 567
Donato, F., Boffetta, P., & Puoti, M. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980130)75:3<347::aid-ijc4>3.0.co;2-2 · Cited by 543
Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis
di Bisceglie, A. M., Goodman, Z. D., Ishak, K. G., Hoofnagle, J. H., Melpolder, J. J., & Alter, H. J. (1991) · Hepatology · doi:10.1002/hep.1840140603 · Cited by 539
Armstrong, G. L., Alter, M. J., McQuillan, G. M., & Margolis, H. S. (2000) · Hepatology · doi:10.1002/hep.510310332 · Cited by 523
(2011) · Hepatogastroenterology · doi:10.5754/hge11232 · Cited by 511
Ikeda, K., Saitoh, S., Arase, Y., Chayama, K., Suzuki, Y., Kobayashi, M., Tsubota, A., Kobayashi, M., Nakamura, I., Murashima, N., et al. (1999) · Hepatology · doi:10.1002/hep.510290439 · Cited by 467
Risk Factors for the Rising Rates of Primary Liver Cancer in the United States
El-Serag, H. B., & Mason, A. C. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.21.3227 · Cited by 418
Self-citationDeterminants of outcome of compensated hepatitis C virus-related cirrhosis
Serfaty, L., Aumaître, H., Chazouillères, O., Bonnand, A.-M., Rosmorduc, O., Poupon, R. E., & Poupon, R. Y. (1998) · Hepatology · doi:10.1002/hep.510270535 · Cited by 403
Reid, A. E. (2001) · Gastroenterology · doi:10.1053/gast.2001.27126 · Cited by 394
Guadagnino, V, Stroffolini, T., Rapicetta, M., Costantino, A., Kondili, L. A., Menniti-Ippolito, F., Caroleo, B., Costa, C., Griffo, G., Loiacono, L., et al. (1997) · Hepatology · doi:10.1002/hep.510260431 · Cited by 389
Excess Risk of Primary Liver Cancer in Patients With Diabetes Mellitus
Adami, H.-O., Chow, W.-H., Nyren, O., Berne, C., Linet, M. S., Ekbom, A., Wolk, A., McLaughlin, J. K., & Fraumeni, J. F. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.20.1472 · Cited by 373
Hepatitis C Virus Genotypes and Risk of Hepatocellular Carcinoma in Cirrhosis: A Prospective Study
Bruno, S., Silini, E., Crosignani, A., Borzio, F., Leandro, G., Bono, F., Asti, M., Rossi, S., Larghi, A., Cerino, A., et al. (1997) · Hepatology · doi:10.1002/hep.510250344 · Cited by 358
Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: an evidence-based approach
Cammà, C., Giunta, M., Andreone, P., & Craxı̀, A. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00005-8 · Cited by 356
Simonetti, R. G., Cammà, C., Fiorello, F., Cottone, M., Rapicetta, M., Marino, L., Fiorentino, G., Craxì, A., Ciccaglione, A., Giuseppetti, R., et al. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-2-97 · Cited by 354
El-Serag, H. B., Mason, A. C., & Key, C. (2001) · Hepatology · doi:10.1053/jhep.2001.21041 · Cited by 353
Self-citationRelation of Interferon Therapy and Hepatocellular Carcinoma in Patients with Chronic Hepatitis C
Imai, Y., Kawata, S., Tamura, S., Yabuuchi, I., Noda, S., Inada, M., Maeda, Y., Shirai, Y., Fukuzaki, T., Kaji, I., et al. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-2-199807150-00005 · Cited by 338
Trends in primary liver cancer
Deuffic, S., Poynard, T., Buffat, L., & Valleron, A.-J. (1998) · The Lancet · doi:10.1016/s0140-6736(05)78179-4 · Cited by 316
HCV-associated liver cancer without cirrhosis
De Mitri, M. S., Pisi, E., Poussin, K., Paterlini, P., Bréchot, C., Baccarini, P., D'Errico, A., Grigiani, W., Alberti, A., Pontisso, P., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90400-x · Cited by 294
Psychiatric disorders among veterans with hepatitis C infection
El–Serag, H. B., Kunik, M., Richardson, P., & Rabeneck, L. (2002) · Gastroenterology · doi:10.1053/gast.2002.34750 · Cited by 283
Self-citationThe role of diabetes in hepatocellular carcinoma: a case-control study among United States veterans
El-Serag, H. (2001) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(01)02617-x · Cited by 274
Self-citationBralet, M.-P., Régimbeau, J.-M., Pineau, P., Dubois, S., Loas, G., Degos, F., Valla, D., Belghiti, J., Degott, C., & Terris, B. (2000) · Hepatology · doi:10.1053/jhep.2000.9033 · Cited by 249
Natural history of hepatitis C
Seeff, L. B. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00374-5 · Cited by 239
Okanoue, T., Itoh, Y., Minami, M., Sakamoto, S., Yasui, K., Sakamoto, M., Nishioji, K., Murakami, Y., & Kashima, K. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80196-2 · Cited by 237
Hepatitis C-associated hepatocellular carcinoma
Hasan, F., Jeffers, L. J., De Medina, M., Reddy, R. K., Parker, T., Schiff, E. R., Houghton, M., Choo, Q., & Kuo, G. (1990) · Hepatology · doi:10.1002/hep.1840120323 · Cited by 235
Donato, F., Tagger, A., Chiesa, R., Ribero, M. L., Tomasoni, V, Fasola, M., Gelatti, U., Portera, G., Boffetta, P., & Nardi, G. (1997) · Hepatology · doi:10.1002/hep.510260308 · Cited by 234
(1998) · The Lancet · doi:10.1016/s0140-6736(98)07236-5 · Cited by 230
Yoshizawa, H. (2002) · Oncology · doi:10.1159/000048270 · Cited by 229
Valla, D.-C., Chevallier, M., Marcellin, P., Payen, J.-L., Trepo, C., Fonck, M., Bourliere, M., Boucher, E., Miguet, J.-P., Parlier, D., et al. (1999) · Hepatology · doi:10.1002/hep.510290616 · Cited by 211
Yu, M. C., Henderson, B. E., Tong, M. J., & Govindarajan, S. (1991) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/83.24.1820 · Cited by 190
Yu, M. C., Tong, M. J., Coursaget, P., Ross, R. K., Govindarajan, S., & Henderson, B. E. (1990) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/82.12.1038 · Cited by 175
The natural history of chronic hepatitis C in haemophiliacs
Makris, M., Preston, F. E., Rosendaal, F. R., Underwood, J. C. E., Rice, K. M., & Triger, D. R. (1996) · British Journal of Haematology · doi:10.1046/j.1365-2141.1996.02343.x · Cited by 170
Role of Diabetes Mellitus in the Etiology of Hepatocellular Carcinoma
Lagiou, P. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.13.1096 · Cited by 162
Diabetes mellitus and the risk of primary liver cancer
Vecchia, C. L., Negri, E., Decarli, A., & Franceschi, S. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19971009)73:2<204::aid-ijc7>3.0.co;2-# · Cited by 145
Clinical outcome of hepatitis C as a function of mode of transmission
Gordon, S. C., Bayati, N., & Silverman, A. L. (1998) · Hepatology · doi:10.1002/hep.510280238 · Cited by 131
Bac, C. D., Stroffolini, T., Gaeta, G. B., Taliani, G., & Giusti, G. (1994) · Hepatology · doi:10.1016/0270-9139(94)90761-7 · Cited by 131
López‐Labrador, F. X., Ampurdanés, S., Forns, X., Castells, A., Sáiz, J., Costa, J. M., Bruix, J., Tapias, J. M. S., de Anta, M. T. J., & Rodés, J. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)80137-7 · Cited by 117
Chiaramonte, M., Stroffolini, T., Lorenzoni, U., Minniti, F., Conti, S., Floreani, A., Ntakirutimana, E., Vian, A., Ngatchu, T., & Naccarato, R. (1996) · Journal of Hepatology · doi:10.1016/s0168-8278(96)80020-1 · Cited by 115
A case-control study of primary hepatocellular carcinoma in Taiwan
Lu, S., Lin, T., Chen, C., Chen, J. S., Liaw, Y., Chang, W., & Hsu, S. T. (1988) · Cancer · doi:10.1002/1097-0142(19881101)62:9<2051::aid-cncr2820620930>3.0.co;2-1 · Cited by 110
Impact of interferon therapy on the natural history of hepatitis C virus related cirrhosis
Gramenzi, A., Andreoné, P., Fiorino, S., Cammà, C., Giunta, M., Magalotti, D., Cursaro, C., Calabrese, C., Arienti, V., Rossi, C., et al. (2001) · Gut · doi:10.1136/gut.48.6.843 · Cited by 88
Tiribelli, C., Melato, M., Crocè, L. S., et al. (1989) · Hepatology · doi:10.1002/hep.1840100618 · Cited by 85
Bruno, S., Battezzati, P. M., Bellati, G., Manzin, A., Maggioni, M., Crosignani, A., Borzio, M., Solforosi, L., Morabito, A., Ideo, G., et al. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00062-9 · Cited by 78
Correlation between hepatitis C virus prevalence and hepatocellular carcinoma mortality in Europe
Deuffic‐Burban, S., Poynard, T., & Valleron, A. (1999) · Journal of Viral Hepatitis · doi:10.1046/j.1365-2893.1999.00178.x · Cited by 67
Hepatitis C-Related Hepatocellular Carcinoma
Rh, R. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.153.14.1672 · Cited by 66
Attributable risks for hepatocellular carcinoma in Northern Italy
Braga, C., Vecchia, C. L., Negri, E., & Franceschi, S. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(96)00500-x · Cited by 61
(1998) · European Journal of Cancer Prevention · doi:10.1097/00008469-199802001-00076 · Cited by 26
19 Hepatitis C virus infection and alcohol
Everhart, J. E., & Herion, D. W. (2000) · Biomedical research reports · doi:10.1016/s1874-5326(00)80023-x · Cited by 11
Cited by
Schuppan, D., & Afdhal, N. H. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60383-9 · Cited by 2,089
Davis, G. L., Alter, M. J., El–Serag, H., Poynard, T., & Jennings, L. W. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.09.067 · Cited by 878
Self-citationLok, A. S., Seeff, L. B., Morgan, T. R., di Bisceglie, A. M., Sterling, R. K., Curto, T. M., Everson, G. T., Lindsay, K. L., Lee, W. M., Bonkovsky, H. L., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.09.014 · Cited by 651
Salem, R., Lewandowski, R. J., Kulik, L., Wang, E., Riaz, A., Ryu, R. K., Sato, K. T., Gupta, R., Nikolaidis, P., Miller, F. H., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.10.049 · Cited by 650
Prognosis of hepatocellular carcinoma: Comparison of 7 staging systems in an American cohort†
Marrero, J. A., Fontana, R. J., Barrat, A., Askari, F., Conjeevaram, H. S., Su, G. L., & Lok, A. S. (2005) · Hepatology · doi:10.1002/hep.20636 · Cited by 637
Metadata
- Authors
- El-Serag, H. B.
- Venue
- Hepatology
- Published
- 2002-11
- Volume
- 36
- Issue
- Supplement 1
- Pages
- S74-S83
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W4239073631
- Cited by
- 291
- References
- 59
- FWCI
- 12.34
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.